ABEC, a global leader in customized solutions and services for biopharmaceutical manufacturing, announced the grand opening of its newest manufacturing facility in Wilson, North Carolina.
The new Wilson facility expands ABEC's global manufacturing network and strengthens the company's ability to support the rapidly growing biopharmaceutical industry with industry-leading equipment, consumables, and integrated process solutions. Strategically located in one of the nation's fastest-growing life sciences regions, the facility enhances ABEC's manufacturing capacity while creating new high-quality manufacturing and technical employment opportunities in eastern North Carolina.
"Opening our Wilson facility represents another important milestone in ABEC's commitment to supporting the global biopharmaceutical industry," said Scott Pickering, Chief Executive Officer of ABEC. "This investment expands our manufacturing capabilities, brings us closer to customers in the southeastern United States, and reinforces our ability to deliver the industry's most comprehensive portfolio of bioprocess equipment, consumables, and engineering solutions. We are proud to become part of the Wilson community and look forward to building long-term partnerships throughout the region."
The Wilson facility will manufacture bioprocess equipment and consumable products used in the development and production of life-saving biologics, vaccines, and other advanced medicines. The site complements ABEC's existing manufacturing operations in Bethlehem, Pennsylvania; Springfield, Missouri; Fermoy, Ireland; and Kells, Ireland, further strengthening the company's position as the biopharmaceutical industry's largest dedicated manufacturing network for process equipment and solutions.